|Podcasts|February 7, 2023
The Rewarding Path Of Science
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. Sean Bohen, CEO of Olema Oncology, discusses his career and significant contributions to the clinical research and development of numerous oncology drugs that received regulatory approval for various indications. Plus a look at Olema, how they operate, and challenges they face.
Related Content
Trending on Applied Clinical Trials Online
1
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
2
Lab Orchestration Is Not What You Think It Is
3
Why Patient Input Comes in Too Late—and What Earlier Engagement Changes
4
Recruitment in the Age of AI: Q&A with John Worden, Javara
5